Annual CFI
-$163.06 M
+$283.17 M+63.46%
31 December 2023
Summary:
Jazz Pharmaceuticals annual cash flow from investing activities is currently -$163.06 million, with the most recent change of +$283.17 million (+63.46%) on 31 December 2023. During the last 3 years, it has risen by +$844.61 million (+83.82%). JAZZ annual CFI is now -3155.31% below its all-time high of $5.34 million, reached on 31 December 2007.JAZZ Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$214.09 M
+$471.18 M+183.27%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly cash flow from investing activities is currently $214.09 million, with the most recent change of +$471.18 million (+183.27%) on 30 September 2024. Over the past year, it has increased by +$388.39 million (+222.83%). JAZZ quarterly CFI is now -70.96% below its all-time high of $737.13 million, reached on 31 March 2021.JAZZ Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$213.11 M
+$388.39 M+64.57%
30 September 2024
Summary:
Jazz Pharmaceuticals TTM cash flow from investing activities is currently -$213.11 million, with the most recent change of +$388.39 million (+64.57%) on 30 September 2024. Over the past year, it has increased by +$376.13 million (+63.83%). JAZZ TTM CFI is now -387.88% below its all-time high of $74.03 million, reached on 30 September 2013.JAZZ TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.5% | +222.8% | +63.8% |
| 3 y3 years | +83.8% | +898.4% | +95.8% |
| 5 y5 years | +58.7% | +234.1% | -587.2% |
JAZZ Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +96.9% | at high | +166.0% | -61.5% | +96.4% |
| 5 y | 5 years | -5.0% | +96.9% | -71.0% | +103.6% | -587.2% | +96.4% |
| alltime | all time | -3155.3% | +96.9% | -71.0% | +103.6% | -387.9% | +96.4% |
Jazz Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $214.09 M(-183.3%) | -$213.11 M(-64.6%) |
| June 2024 | - | -$257.09 M(-5.4%) | -$601.50 M(+39.8%) |
| Mar 2024 | - | -$271.90 M(-367.1%) | -$430.14 M(+163.8%) |
| Dec 2023 | -$163.06 M(-63.5%) | $101.80 M(-158.4%) | -$163.06 M(-72.3%) |
| Sept 2023 | - | -$174.30 M(+103.3%) | -$589.24 M(+43.6%) |
| June 2023 | - | -$85.74 M(+1678.1%) | -$410.34 M(-0.8%) |
| Mar 2023 | - | -$4.82 M(-98.5%) | -$413.76 M(-7.3%) |
| Dec 2022 | -$446.23 M(-91.4%) | -$324.38 M(-7148.6%) | -$446.23 M(+238.2%) |
| Sept 2022 | - | $4.60 M(-105.2%) | -$131.94 M(-19.2%) |
| June 2022 | - | -$89.16 M(+139.1%) | -$163.36 M(-97.3%) |
| Mar 2022 | - | -$37.29 M(+269.5%) | -$5.99 B(+14.9%) |
| Dec 2021 | -$5.21 B(+417.2%) | -$10.09 M(-62.4%) | -$5.21 B(+1.6%) |
| Sept 2021 | - | -$26.81 M(-99.5%) | -$5.13 B(-4.7%) |
| June 2021 | - | -$5.91 B(-902.1%) | -$5.38 B(+2457.1%) |
| Mar 2021 | - | $737.13 M(+906.7%) | -$210.46 M(-79.1%) |
| Dec 2020 | -$1.01 B(+548.9%) | $73.22 M(-126.2%) | -$1.01 B(-18.7%) |
| Sept 2020 | - | -$279.64 M(-62.3%) | -$1.24 B(+10.7%) |
| June 2020 | - | -$741.16 M(+1133.6%) | -$1.12 B(+193.6%) |
| Mar 2020 | - | -$60.08 M(-62.2%) | -$381.43 M(+145.6%) |
| Dec 2019 | -$155.30 M(-60.6%) | -$159.05 M(-0.4%) | -$155.30 M(-455.0%) |
| Sept 2019 | - | -$159.66 M(+5952.4%) | $43.74 M(+275.2%) |
| June 2019 | - | -$2.64 M(-101.6%) | $11.66 M(-106.6%) |
| Mar 2019 | - | $166.05 M(+315.2%) | -$176.29 M(-55.3%) |
| Dec 2018 | -$394.49 M(+46.7%) | $39.99 M(-120.9%) | -$394.49 M(-15.4%) |
| Sept 2018 | - | -$191.75 M(+0.6%) | -$466.36 M(-2.4%) |
| June 2018 | - | -$190.58 M(+265.5%) | -$477.96 M(+50.5%) |
| Mar 2018 | - | -$52.15 M(+63.6%) | -$317.52 M(+18.1%) |
| Dec 2017 | -$268.95 M(-84.6%) | -$31.88 M(-84.3%) | -$268.95 M(+12.6%) |
| Sept 2017 | - | -$203.35 M(+574.4%) | -$238.93 M(-84.7%) |
| June 2017 | - | -$30.15 M(+743.6%) | -$1.57 B(-10.1%) |
| Mar 2017 | - | -$3.57 M(+92.3%) | -$1.74 B(-0.5%) |
| Dec 2016 | -$1.75 B(>+9900.0%) | -$1.86 M(-99.9%) | -$1.75 B(-0.1%) |
| Sept 2016 | - | -$1.53 B(+642.3%) | -$1.75 B(+672.8%) |
| June 2016 | - | -$206.27 M(+1619.6%) | -$226.79 M(+596.9%) |
| Mar 2016 | - | -$11.99 M(+256.3%) | -$32.54 M(+1343.1%) |
| Dec 2015 | -$2.25 M | -$3.37 M(-34.7%) | -$2.25 M(-82.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | -$5.16 M(-57.1%) | -$13.06 M(-85.7%) |
| June 2015 | - | -$12.02 M(-165.7%) | -$91.04 M(-1.2%) |
| Mar 2015 | - | $18.29 M(-229.1%) | -$92.15 M(-91.4%) |
| Dec 2014 | -$1.07 B(+6464.5%) | -$14.17 M(-83.0%) | -$1.07 B(+1.0%) |
| Sept 2014 | - | -$83.14 M(+533.1%) | -$1.06 B(+8.2%) |
| June 2014 | - | -$13.13 M(-98.6%) | -$976.59 M(+1.0%) |
| Mar 2014 | - | -$957.20 M(>+9900.0%) | -$967.02 M(+5845.8%) |
| Dec 2013 | -$16.26 M(-95.9%) | -$3.10 M(-1.6%) | -$16.26 M(-122.0%) |
| Sept 2013 | - | -$3.15 M(-11.6%) | $74.03 M(+0.8%) |
| June 2013 | - | -$3.57 M(-44.6%) | $73.43 M(-115.2%) |
| Mar 2013 | - | -$6.44 M(-107.4%) | -$484.25 M(+22.5%) |
| Dec 2012 | -$395.29 M(+386.6%) | $87.19 M(-2425.7%) | -$395.29 M(-27.9%) |
| Sept 2012 | - | -$3.75 M(-99.3%) | -$548.08 M(-1.8%) |
| June 2012 | - | -$561.24 M(-780.2%) | -$557.96 M(<-9900.0%) |
| Mar 2012 | - | $82.51 M(-225.8%) | $2.47 M(-103.0%) |
| Dec 2011 | -$81.23 M(+3690.6%) | -$65.60 M(+381.6%) | -$81.23 M(+385.1%) |
| Sept 2011 | - | -$13.62 M(+1561.2%) | -$16.75 M(+326.1%) |
| June 2011 | - | -$820.00 K(-31.2%) | -$3.93 M(-8.3%) |
| Mar 2011 | - | -$1.19 M(+7.0%) | -$4.29 M(+100.0%) |
| Dec 2010 | -$2.14 M(-65.0%) | -$1.11 M(+38.1%) | -$2.14 M(-64.7%) |
| Sept 2010 | - | -$806.00 K(-31.4%) | -$6.07 M(-15.3%) |
| June 2010 | - | -$1.18 M(-223.6%) | -$7.17 M(+13.7%) |
| Mar 2010 | - | $951.00 K(-118.9%) | -$6.31 M(+3.0%) |
| Dec 2009 | -$6.12 M(-48.7%) | -$5.04 M(+164.8%) | -$6.12 M(-24.2%) |
| Sept 2009 | - | -$1.91 M(+510.6%) | -$8.07 M(<-9900.0%) |
| June 2009 | - | -$312.00 K(-127.4%) | $51.00 K(-100.6%) |
| Mar 2009 | - | $1.14 M(-116.3%) | -$7.88 M(-34.0%) |
| Dec 2008 | -$11.94 M(-323.8%) | -$6.99 M(-212.4%) | -$11.94 M(-367.9%) |
| Sept 2008 | - | $6.22 M(-175.5%) | $4.46 M(-133.7%) |
| June 2008 | - | -$8.24 M(+181.6%) | -$13.23 M(+112.3%) |
| Mar 2008 | - | -$2.93 M(-131.1%) | -$6.23 M(-216.8%) |
| Dec 2007 | $5.34 M(-454.1%) | $9.40 M(-182.0%) | $5.34 M(-231.2%) |
| Sept 2007 | - | -$11.47 M(+823.5%) | -$4.07 M(-155.0%) |
| June 2007 | - | -$1.24 M(-114.4%) | $7.40 M(-14.4%) |
| Mar 2007 | - | $8.64 M | $8.64 M |
| Dec 2006 | -$1.51 M(-99.0%) | - | - |
| Dec 2005 | -$153.75 M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual CFI year-on-year change?
- What is Jazz Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly CFI year-on-year change?
- What is Jazz Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM CFI year-on-year change?
What is Jazz Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of JAZZ is -$163.06 M
What is the all time high annual CFI for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual cash flow from investing activities is $5.34 M
What is Jazz Pharmaceuticals annual CFI year-on-year change?
Over the past year, JAZZ annual cash flow from investing activities has changed by +$283.17 M (+63.46%)
What is Jazz Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of JAZZ is $214.09 M
What is the all time high quarterly CFI for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly cash flow from investing activities is $737.13 M
What is Jazz Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, JAZZ quarterly cash flow from investing activities has changed by +$388.39 M (+222.83%)
What is Jazz Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of JAZZ is -$213.11 M
What is the all time high TTM CFI for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM cash flow from investing activities is $74.03 M
What is Jazz Pharmaceuticals TTM CFI year-on-year change?
Over the past year, JAZZ TTM cash flow from investing activities has changed by +$376.13 M (+63.83%)